News
After reviewing several large epidemiological studies, clinical trial and in-market data, EMA’s Pharmacovigilance Risk Assessment Committee has concluded non-anterior ischemic optic neuropathy is a ...
In the past, studies in type-2 diabetes patients have linked Ozempic to the condition called non-arteritic anterior ischemic ...
MBX Biosciences is advancing a unique prodrug pipeline with key GLP-1 assets and a pivotal Phase 2 readout in ...
Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...
They have been called miraculous and the fastest way to lose weight. From Wegovy to Mounjaro, here’s how GLP-1 drugs work ...
With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.
The mineralocorticoid receptor plays a significant role in the development of chronic kidney disease (CKD) and associated cardiovascular complications. Classic steroidal mineralocorticoid receptor ...
People with kidney disease are among the most at risk during humanitarian emergencies. 6,7 The proposed resolution emphasises kidney health promotion, preventive measures, and access to cost-effective ...
Queen Latifah has partnered with Novo Nordisk to bring awareness to obesity and heart health, and the seriousness behind the ...
The government is also currently negotiating lower prices for Novo Nordisk’s Wegovy and Ozempic in Medicare under the Inflation Reduction Act. The new rates, which take effect in 2027 ...
Starting in 2022, increased demand led to shortages of semaglutide injections sold by Novo Nordisk under the brand names Ozempic and ... that obesity is a chronic disease.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results